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Abstract Objectives: To evaluate long-term outcome of initial aortic valve intervention in a paediatric population
with congenital aortic stenosis, and to determine risk factors associated with reintervention. Patients and methods:
From 1985 to 2009, 77 patients with congenital aortic stenosis and a mean age of 5.8± 5.6 years at diagnosis
were followed up in our institution for 14.8± 9.1 years. Results: First intervention was successful with 86% of
patients having a residual peak aortic gradient <50 mmHg, and the proportion of patients with grade >1
regurgitation increased by 7%. Long-term survival after the ﬁrst procedure was excellent, with 91% survival at
25 years. At a mean interval of 7.6± 5.3 years, 30 patients required a reintervention (39%), mainly because of a
recurrent aortic stenosis. Freedom from reintervention was 97, 89, 75, 53, and 42% at 1, 10, 15, 20, and 25 years,
respectively. Predictors of reintervention were residual peak aortic gradient (p= 0.0001), aortic regurgitation
post-intervention >1 (p= 0.02), prior balloon aortic valvuloplasty (p= 0.04), and increased left ventricular
posterior wall thickness (p= 0.1). Conclusions: Aortic valve intervention is a safe and effective procedure for
congenital aortic stenosis with excellent survival results. However, rate of reintervention is high and inﬂuenced
by increased left ventricular posterior wall thickness pre-intervention, prior balloon valvuloplasty, higher residual
peak systolic valve gradient, and more than mild regurgitation post-intervention. The study highlights that
long-term follow-up is recommended for these patients.
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AORTIC VALVE STENOSIS IS THE MOST FREQUENTvalvular heart disease and represents 2–5% ofall congenital heart anomalies.1–2 The natural
history of congenital aortic valve stenosis is well
documented and described as a progressive lesion
with high risk of sudden cardiac death. The overall
25-year survival in aortic valve stenosis is 85% with
59% of patients ultimately requiring intervention.3
Surgical aortic valvotomy, introduced by Lillehei in
1956, was the only therapeutic option until 1983, when
Lababidi introduced the aortic balloon valvotomy.4–5
Nowadays, both techniques show comparable early
results,6–9 and the choice of treatment seems to vary
more according to local expertise and/or preference as
well as the age of the patient. Owing to restenosis
or residual regurgitation, the ﬁrst intervention is
often palliative and reintervention is necessary sooner
or later. In the literature, 85–95% of children
and young adults are free of reintervention for at least
10 years. At 20 and 40 years after initial intervention,
only 60 and 10% of patients will be free of rein-
tervention, respectively.2
Predicting long-term outcomes of patients with
congenital aortic stenosis has proven to be a clinical
challenge, largely because mechanism of restenosis
and residual regurgitation is not well known. The
purpose of this retrospective study is to describe the
long-term outcomes of aortic valve stenosis during a
25-year follow-up, and to investigate early and late
determinant factors of reintervention.
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Materials and methods
Patient selection
All patients <16 years of age with a congenital narrow-
ing of the aortic valve were identiﬁed as patients with
a congenital aortic stenosis. The follow-up took
place from January 1985 to December 2009 in our
institution. At least, pre- and post-intervention
medical data and echocardiographic examinations
were required to be included. Exclusion criteria were
any other associated cardiac malformations inﬂuen-
cing the decision to operate on the heart. During the
25-year follow-up, a total of 167 patients were identi-
ﬁed; of them, 57 were excluded because of documented
associated malformations or incomplete medical data
and of the 110 patients left, 77 underwent an inter-
vention and were eligible for the study.
For the statistical analysis and the determination of
predictors of reintervention, the 77 patients were
divided into two groups: a group of patients with
intervention and no reintervention (group A); and a
group of patients with intervention and reintervention
(group B).
Ethical approval and data collection was obtained
according to the guidelines of the ethical committee
for clinical research of our University Hospital.
Clinical data
Patients were identiﬁed using the medical and
echocardiographic database. Variables included
demographic information, clinical status, echocardio-
graphic, and haemodynamic data reviewed by the same
investigator. We deﬁned the clinical status as “normal”
in asymptomatic patients, and as “reduced” in patients
with symptoms of dyspnoea, syncope, angina pectoris,
fatigue on exertion, cardiogenic shock, left ventricular
strain on the ECG, low cardiac output, and severe left
ventricular dysfunction. End-points were deﬁned as
aortic valve intervention, reintervention, and death
during follow-up.
Echocardiographic data
All standard echocardiographic examinations were
conducted without sedation by a paediatric cardiologist.
Left ventricular morphologic criteria were derived from
M-mode analysis. As cardiac dimensions and body
surface change non-linearly during normal growth and
development, the Haycock formula of body surface
area was used to index these recorded parameters: left
ventricular end-systolic and end-diastolic diameter,
interventricular septum thickness, left ventricular pos-
terior wall thickness, and aortic annulus diameter.10
Moreover, these variables were standardised according
to the Z-score, to enhance comparison between
individuals.11 The aortic jet velocity was recorded
with continuous-wave Doppler and used to calculate
the peak aortic gradient.12 In our institution and
according to the guidelines,13 a peak aortic gradient
>50 mmHg in symptomatic patients and a peak
aortic gradient >60 mmHg in asymptomatic
patients were indicators for intervention. On the basis
of colour ﬂow imaging, aortic regurgitation severity
was graded from none to severe (grade 0–3).
The bicuspid valve is deﬁned as an aortic valve
formed of two leaﬂets or functioning like a two-leaﬂet
valve. The denomination dysplasia is deﬁned by using a
standardised system developed in this study including
thickening, ﬁbrosis, or hypoplasia of the valve leaﬂets.
Statistical analysis
All statistical analyses were performed using Statistical
Analysis Software JPM version 8.02 (SAS Institute,
Cary, New Jersey, United States of America). Univariate
analysis with the parametric tests (paired t-test, χ2-test,
or Pearson regression) was performed to identify differ-
ences between categories of possible predictors compared
with the end-points: intervention, reintervention, and
death. The mean and standard deviations were derived
for the continuous variables. Categorical variables were
expressed as counts and percentages. Multivariate ana-
lysis was performed using stepwise multiple linear
regressions to determine independent predictors of
reintervention. Variables with a p-value 0.10 in the
univariate analysis were included in the stepwise mul-
tivariable ﬁt model. Kaplan-Meier survival analysis was
used to estimate probabilities of reintervention-free
survival rates for the levels of various prognostic factors,
and to estimate the overall survival rates from the time
of admission to death. For patients who did not reach
end-point death, the data were censored at the time of
hospital discharge, last echocardiographic examination
recorded, or at the time of end of the study. Risk ratio
and 95% conﬁdence intervals were calculated using a
Cox proportional hazards model. A p-value <0.05 was
considered as statistically signiﬁcant.
Results
Characteristics of patients
From January, 1985 to December, 2009, 77 patients
who underwent intervention with congenital aortic
valve stenosis were identiﬁed with a majority of male
patients (n= 51, 66%) (Table 1). The mean age of the
cohort was 5.8± 5.6 years. At diagnosis, 29 patients
were <1 year old (38%), and 11 patients were
<1 month old (14%). A bicuspid aortic valve was
found in 56 patients (73%), a tricuspid valve in
20 (26%), and a unicuspid valve in one patient (1%).
A muscular or ﬁbromuscular subvalvular stenosis was
associated in 17 cases (22%). A total of 49 patients
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(64%) had an aortic valve dysplasia with ﬁbrotic,
thickened, or hypoplastic leaﬂets. The majority of the
patients (n=55, 71%) were symptomatic at diagnosis
(Table 2), with 14 patients <1 year of age (18%)
showing symptoms of congestive heart failure, such as
dyspnoea or fatigue on exertion.
Themean peak aortic gradient before intervention was
evaluated at 92±30mmHg; more precisely, 75 patients
(97%) had a peak aortic gradient>50mmHg, 69 (90%)
had a gradient >60mmHg, and 57 (74%) had a
gradient >75mmHg. At the time of intervention,
67 patients (87%) had no or mild aortic regurgitation
(grade 0–1). Signs of left ventricular hypertrophy with
strain on ECG were found in three patients (3%).
Immediate results
The initial intervention was a surgical aortic valvotomy
in 42 patients (55%), a percutaneous balloon aortic
valvuloplasty in 22 patients (29%), a Ross procedure
in six patients (8%), an aortic valve replacement in six
patients (8%), and an aortic homograft replacement
in one patient (1%).
The mean residual peak systolic valve gradient was
35 mmHg after intervention. Of the patients, 11 had
residual gradients >50 mmHg (14%). The mean
immediate peak systolic gradient was reduced by an
average of 63% after the procedure. A gradient
reduction of more than 40% occurred in 66 patients
(86%).
The ﬁrst intervention resulted in an increase of the
proportion of patients with grade >1 regurgitation
by 7% (from 13 to 20%). However, only 3% of
the patients had a post-intervention regurgitation
grade >3.
A total of four deaths (9%) were associated with the
ﬁrst intervention. Of these, three deaths happened
in patients <1 month of age, two after surgical aortic
Table 1. Baseline patient characteristics.
Total
Intervention with no
reintervention (group A)
Intervention with
reintervention (group B)
Number of patients 77 47 30
Age at diagnosis (months) 69.7± 67.1 80.6± 68.7 52.6± 62.1
Patients with age at diagnosis <1 year 29 (38%) 14 (30%) 15 (50%)
Patients with age at diagnosis <1 month 11 (14%) 7 (15%) 4 (13%)
Median body length (cm) 101.3 107.1± 39.9 92.2± 33.6
Median body weight (kg) 20.6 23.3± 17.8 16.4± 12.8
Gender ratio
Male 51 (66%) 31 (66%) 20 (67%)
Female 26 (34%) 16 (34%) 10 (33%)
Morphology valve
Tricuspid 20 (26%) 11 (23%) 9 (30%)
Bicuspid 56 (73%) 36 (77%) 20 (67%)
Unicuspid 1 (1%) 1 (3%)
None associated pathologies 49 (64%) 30 (64%) 19 (63%)
Subvalvular stenosis 17 (22%) 11 (23%) 6 (20%)
Dysplastic aortic valve 49 (64%) 30 (64%) 19 (63%)
Number of interventions
One 77 (100%)
Two (reintervention) 30 (39%)
Three 7 (9%)
Four 2 (3%)
First intervention type
Balloon 22 (29%) 7 (15%) 15 (50%)
Valvotomy 42 (55%) 28 (60%) 14 (47%)
Ross 6 (8%) 6 (13%) 0
AVR 6 (8%) 5 (11%) 1 (3%)
Homograft 1 (1%) 1 (2%) 0
First reintervention type
Balloon 0
Valvotomy 5 (17%)
Ross 19 (63%)
AVR 6 (20%)
Homograft
Death total 6 (8%) 4 (9%) 2 (7%)
Death >30 days after the intervention 3 (4%) 2 (4%) 1 (3%)
AVR= aortic valve replacement
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valvotomy, and one after percutaneous balloon aortic
valvuloplasty. Of these three deaths, two occurred in
an interval <30 days after intervention because of
cardiac insufﬁciency, and one happened 45 days after
surgical valvotomy by a cardiac arrest after obstruc-
tion of the endotracheal tube. All of them had a severe
preoperative aortic stenosis. The fourth death occur-
red in a 5.5-year-old patient who had severe con-
gestive heart failure at diagnosis and died in an
interval >30 days after surgical valvotomy.
Long-term results
Clinical follow-up information, including survival
and need for repeat intervention, was available at a
mean follow-up of 13.8± 9.1 years (range 1-431
months, cumulative follow-up of 611 years).
Of the patients who underwent a ﬁrst intervention,
30 (39%) required a reintervention in a mean interval
of 7.6± 5.3 years (range 0.5–251 months). A third
intervention on the aortic valve was necessary in seven
cases (6%), and a fourth intervention in two cases
(2%). Owing to the sample size in what follows only
the ﬁrst reintervention is considered.
The indication for reintervention included rest-
enosis in 17 cases (57%), aortic regurgitation in
two (7%), and a combination of aortic stenosis
and regurgitation in eight patients (27%). All of the
30 patients underwent surgery; none required a
repeat balloon dilatation. A Ross procedure was
necessary in 19 patients (17%), an aortic valve
replacement in six patients (15%), and a surgical
aortic valvotomy in ﬁve patients (5%).
When we evaluate the peak systolic valve gradient
after the ﬁrst procedure, we observe a progression or a
recurrence of the stenosis in 39% of the cases. For
example, 11 of the 30 patients (37%), who had to
undergo a reintervention, presented a peak aortic
gradient >75 mmHg before reintervention compared
with two patients (7%) after ﬁrst intervention, and
15 (50%) patients had a peak aortic gradient >50
mmHg before reintervention compared with six
(20%) after ﬁrst procedure. The mean peak aortic
gradient before reintervention was 73± 20 mmHg.
Table 2. Patients data before and after intervention.
Total
Intervention with no
reintervention (group A)
Intervention with
reintervention (group B)
Number of patients 77 47 30
Asymptomatic 22 (29%) 11 (23%) 11 (37%)
Symptomatic 55 (71%) 36 (77%) 19 (63%)
Variables measured pre-intervention
Mean peak aortic gradient (mmHg) 92± 30 94± 32 90± 26
Peak aortic gradient >50 mmHg 75 (97%) 46 (98%) 29 (97%)
Peak aortic gradient >60 mmHg 69 (90%) 40 (85%) 29 (97%)
Peak aortic gradient >75 mmHg 57 (74%) 34 (72%) 23 (77%)
Mean aortic jet velocity (m/s) 4.7± 1.0 4.7± 0.9 4.7± 0.9
Aortic jet velocity >4 m/s 41 (53%) 26 (55%) 15 (50%)
Aortic regurgitation
Grade 0–1 67 (87%) 38 (81%) 29 (97%)
Grade 2 7 (9%) 6 (13%) 1 (3%)
Grade 3 3 (4%) 3 (6%) 0
Z score LV end-diastolic dimension 0.12 0.13± 2.62 0.11± 2.95
Z score LV end-systolic dimension − 0.15 -0.39± 0.47 0.23± 0.59
Z score IV septum 3.33 3.45± 3.03 3.15± 2.03
Z score LV posterior wall thickness 3.11 2.64± 0.35 3.86± 0.44
Z score aortic annular index 0.92 1.26± 2.31 0.41± 2.29
LV ejection fraction % 77.4 76.4± 12.8 79.0± 14.5
LV fractional shortening % 44.4 44.4± 9.2 44.3± 14.7
Hypertrophy on the ECG 54 (70%) 35 (75%) 19 (65%)
Variables measured post-intervention
Mean residual peak aortic gradient
(mmHg)
35± 20 29± 19 46± 15
Residual peak aortic gradient >30 mmHg 46 (60%) 18 (38%) 28 (93%)
Residual peak aortic gradient >50 mmHg 11 (14%) 5 (11%) 6 (20%)
Aortic regurgitation
Grade 0–1 62 (81%) 41 (87%) 21 (70%)
Grade 2 13 (17%) 6 (13%) 7 (23%)
Grade 3 2 (3%) 0 2 (7%)
IV= interventricular; LV= left ventricular
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A similar effect was documented for the regur-
gitation after intervention. We observe a signiﬁcant
progression of regurgitation at follow-up, with 40%
of these patients having a regurgitation grade >1
before reintervention as compared with 20% imme-
diately after ﬁrst procedure. Patients with regurgita-
tion grade 3 increased from 3% after intervention to
18% at late follow-up.
Long-term survival of patients with aortic stenosis
after ﬁrst procedure was excellent, with 96% survival
at 1 year, 93% survival at 10 years, and 91% at 25
years, respectively (Fig 1). The only two late deaths
were related to reintervention. One patient with a
moderate aortic stenosis died after cardiac arrest at
introduction of anesthesia, and the second one died of
cardiac insufﬁciency by myocardial infarction 60 days
after surgical valvotomy reintervention.
The estimated freedom from reintervention was
97, 89, 75, 53, and 42%, at 1, 10, 15, 20, and 25 years,
respectively (Fig 2).
Factors inﬂuencing long-term results
To evaluate possible predictors of repeat intervention
after the ﬁrst procedure, the 77 patients were divided
into two groups consisting of 47 patients who did not
have a repeat intervention on their aortic valve during
the 25 years of follow-up (group A), and 30 patients
who did (group B). Comparison of pre- and post-
intervention characteristics for group A and group B
are summarised in Table 2, signiﬁcant factors are
described below. Both univariate and multivariate
analyses gave some similar results, suggesting that
only increased left ventricular posterior wall
thickness before intervention, balloon valvuloplasty,
residual peak aortic gradient, and regurgitation grade
>1 after the ﬁrst procedure inﬂuenced signiﬁcantly
time to repeat intervention (Table 3).
Patients who had undergone balloon valvuloplasty
as the ﬁrst procedure signiﬁcantly underwent more
repeat intervention than patients who had undergone
surgical intervention. Estimated reintervention-free
survival after balloon aortic valvuloplasty was 100,
81, 55, 16, and 8% at 1, 10, 15, 20, and 25 years,
respectively, compared with 96, 92, 81, 67, and 56%
for patients with no prior balloon valvuloplasty
(Fig 3). Aortic regurgitation grade >1 after the ﬁrst
procedure independently predicted the chance of
repeat intervention. The proportion of patients
having a reintervention was twice as high when the
aortic regurgitation grade was superior to 1. The
greater the residual peak aortic gradient after procedure,
the higher was the risk of repeat intervention. Moreover,
a gradient cutoff point of 30mmHg immediately after
intervention was shown to be predictive of reinterven-
tion with a sensitivity of 87% and a speciﬁcity of 66%.
Interestingly, the rate of reintervention was also
inﬂuenced by increased left ventricular posterior wall
thickness before intervention.
The remaining variables, including gender, age,
body surface, bicuspid aortic valve, subvalvular stenosis,
dysplastic aortic valve, and surgical aortic valvotomy
had no inﬂuence on time to repeat intervention, as well
as the following pre-intervention values: symptoms,
peak aortic gradient, aortic jet velocity, ejection fraction,
fractional shortening, aortic regurgitation >1, left
ventricular end-systolic and end-diastolic diameter,
interventricular septum thickness, aortic annulus
Figure 1.
Kaplan-Meier estimates of survival after ﬁrst intervention.
Figure 2.
Kaplan-Meier estimates of freedom from reintervention.
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diameter, and hypertrophy signs on the ECG, which
were not found to be signiﬁcant predictors of out-
come (Table 4).
Discussion
We present our experience with 77 consecutive pae-
diatric patients with congenital aortic valve stenosis
followed up in our institution, referral centre for ~1
million inhabitants, during a period of 25 years.
Long-term survival after intervention is excellent;
however, reintervention is frequently required.
Our immediate results after intervention conﬁrm
the ﬁndings of previous studies,6,14–20 namely,
the ﬁrst intervention was successful with a signiﬁcant
reduction in peak aortic and an immaterial increase
in aortic regurgitation of the patients. Mortality
rate in our study stood at 8% compared with other
studies.15,21–25
Figure 3.
Kaplan-Meier estimates of freedom from reintervention from patients
with prior balloon valvuloplasty compared with patients without
prior balloon valvuloplasty.
Table 3. Variables tested by statistical analysis.
Variables in scope for statistical analysis
Age at diagnosis
Patients with age at diagnosis <1 year
Patients with age at diagnosis <1 month
Median body length (cm)
Median body weight (kg)
Gender
Bicuspid aortic valve
Subvalvular stenosis
Dysplastic aortic valve
Balloon aortic valvuloplasty
Surgical aortic valve surgery
Symptomatic
Variables measured pre-intervention
Mean peak aortic gradient (mmHg)
Peak aortic gradient >50 mmHg
Peak aortic gradient >60 mmHg
Peak aortic gradient >75 mmHg
Aortic regurgitation pre-intervention grade >1
Mean aortic jet velocity (m/s)
Z score LV end-diastolic dimension
Z score LV end-systolic dimension
Z score IV septum
Z score LV posterior wall thickness
Z score aortic annular index
LV ejection fraction %
LV fractional shortening %
Hypertrophy on the ECG
Variables measured post-intervention
Mean residual peak aortic gradient (mmHg)
Residual peak aortic gradient >30 mmHg
Residual peak aortic gradient >50 mmHg
Aortic regurgitation post-intervention grade >1
IV= interventricular; LV= left ventricular
Table 4. Predictors of reintervention.
Univariate analysis Multivariate analysis
Odds ratio p-value R2 p-value
Mean residual peak aortic gradient mmHg <0.0001 0.154 0.0001
Residual peak aortic gradient >30 mmHg** 12.59 (3.74–42.37) <0.0001 0.216 <0.0001
Aortic regurgitation post-intervention grade >1 4.2 (1.27–13.92) 0.01 0.207 0.02
Balloon aortic valvuloplasty 4.27 (1.49–12.14) 0.005 0.245 0.04
Z Score LV posterior wall thickness* 0.03 0.271 0.1
Aortic regurgitation pre-intervention grade >1* 0.14 (0.02–1.22) 0.04 0.287 0.20
Patients with age at diagnosis <1 year 2.36 (0.91–6.10) 0.07
Age at intervention 0.07
Median body weight kg 0.07
Median body length cm 0.09
Peak aortic gradient >60 mmHg* 5.07 (0.59–43.53) 0.10
LV= left ventricular
*Measured before the intervention
**Multivariate analysis also performed independently with the 30 mmHg cut-off
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The long-term survival results are good with a
stable survival rate of 91% up to 25 years and are
similar to other studies reporting a 10-year survival of
92–96%.7,21,26–31 Yet, the low incidence of sudden
death seems to support our selection criteria for early
and repeat intervention.
The incidence of repeat intervention in the long
term is important. There are several contemporary
surgical reports describing excellent results with low
reintervention rates (up to 90% free from reopera-
tion at 10 years post-surgery).20,21,27–30,32,33 Our
study shows comparable results in the ﬁrst 10 years
after intervention, but thereafter the freedom from
reintervention decreases signiﬁcantly. Over the past
20 years, much improvement has been made in
interventional catheterisation and surgery, which
should improve long-term results in these patients.
However, these comparisons are of limited value
because of the inconsistent criteria used to determine
the need for repeat intervention. Further investiga-
tion is warranted to optimise patient selection and
appropriate criteria for the timing of reintervention.
Balloon valvuloplasty versus surgical valvotomy
In our study, there was a trend towards more rein-
tervention in the patients who had a prior interven-
tion with balloon valvuloplasty. Interestingly, the
need for aortic valve reintervention after balloon
dilatation was unrelated to age at the ﬁrst procedure
or to severity at presenting aortic stenosis.
Throughout the literature, we found various stu-
dies comparing results of balloon dilatation with
surgical valvotomy.3,6–9,20,22,29,30,32,34–36 However,
these studies have a number of limitations including
retrospective analysis, non-randomised patient
group, comparisons between different time periods,
different lengths of follow-up, and a lack of set cri-
teria for intervention and reintervention. Despite
these limitations, and with a lack of prospective
randomised trials, these studies concede that the
outcomes of balloon dilatation and surgical valvot-
omy are equivalent and that the type of intervention
is not predictive of outcome.6,8,9 This is in contrast
with our ﬁndings that a shorter freedom from rein-
tervention for patients undergoing balloon valvulo-
plasty is certainly because of a change in practice in
our institution, with a more aggressive approach
to aortic valve repair for paediatric patients over the
last decade. Moreover, the technology of balloon
valvuloplasty evolved during the last 25 years, with
regard to size of the balloon and the risk of increasing
aortic regurgitation, and may also explain this con-
trasting ﬁnding.
However, if a treatment strategy is adopted that
uses balloon valvuloplasty as initial palliation instead
of initial aortic valve surgery, patients may beneﬁt
from at least one less open-heart surgery in their life,
thus lowering the risk of reoperation resulting from scar
tissue and decreasing the risk of the neurodevelop-
mental consequences of cardiopulmonary bypass.37
Balloon valvuloplasty is also associated with shorter
hospital stays and recovery periods as well as lower
costs.6,14,31
Aortic regurgitation
As already described in some studies, we identiﬁed
the presence of more than mild aortic regurgitation
immediately after intervention as risk factors for rein-
tervention.20,26,38 In addition, the 20% incidence rate
of signiﬁcant aortic regurgitation immediately after
intervention, and the 40% incidence rate at follow-up,
are of concern. The increase in aortic regurgitation over
the period of follow-up reﬂects the progressive nature of
this disorder. The observation that the degree of aortic
regurgitation increases over time is universal, and is
common to all case series, whether related to catheter or
surgical intervention.14,20–23,33,39–41 In the literature,
we observed a 7-19% increase in the degree of aortic
regurgitation directly after intervention,16,20,31,38 and a
10-45% incidence of signiﬁcant aortic regurgitation at
late follow-up.8,14,23–25,31,34,38,39
Although risk factors for increasing aortic regur-
gitation have not been fully deﬁned, it has been
speculated that this is an inevitable occurrence
because of the intrinsically abnormal morphology of
the aortic valve, reﬂecting the modiﬁed natural his-
tory of this disorder. This is not surprising, con-
sidering that either the balloon of the interventionist,
or the scalpel of the surgeon, cause variable splitting
of the fused zones of apposition of the leaﬂets, this being
the primary mechanism for valve dysfunction.42 Indeed,
inspection at surgery shows commissural avulsion,
tearing, perforation, extensive scarring, and calciﬁca-
tion.43,44 Tear, perforation, or partial detachment could
be easily explained by procedure.42 Furthermore, blow
ﬂow through the aortic valve leads to constant haemo-
dynamic trauma.
Although it has been suggested that aortic regur-
gitation may be more frequent after balloon dilatation
than surgical valvotomy,9 data from our institution
were also tested for these parameters but do not support
this view, as described in other studies.8,31 At late fol-
low-up, aortic regurgitation increased signiﬁcantly in
both surgically and balloon dilated cohorts.
Residual peak aortic gradient
Congenital aortic valve stenosis is a progressive lesion and
risk of reintervention after initial procedure on aortic
valve stenosis is high.20,21,23,33,36,41 Most series identify
the higher residual gradients or a progressive and
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recurrent systolic pressure gradient after the ﬁrst proce-
dure as predictors for reintervention.7,26,31,34,38,40,45
In our study, the outcome of the ﬁrst intervention
on aortic valve stenosis in terms of immediate gra-
dient reduction is comparable to that reported by
others.6,7,15–18,20,25,34,46 This attests the efﬁcacy of
aortic ﬁrst intervention in relieving left ventricular
outﬂow tract obstruction and conﬁrms previous
reports. However, 14% of the patients had acute
residual gradient of 50 mmHg or greater, and 39% of
the patients showed a progressive or recurrent systolic
pressure gradient at late follow-up. Indeed, although
in group A the peak aortic gradient after intervention
remains low for many years, conﬁrming a favourable
and long-lasting success of ﬁrst intervention in
reducing the left ventricular pressure load in this
group, in group B a signiﬁcant increase in residual
gradients was documented. Therefore, not surpris-
ingly in our population, and in accordance with the
results reported in the literature,47,48 most of the
reinterventions performed on the aortic valve were
because of restenosis or persistent residual gradient.
More precisely, we identiﬁed a residual gradient
immediately subsequent to the procedure >30
mmHg as a risk factor for reintervention. It conﬁrms
the ﬁndings of two previous studies. Pedra et al14
found the risk of reintervention as increasing loga-
rithmically for values of >30 mmHg. Galal et al36
identiﬁed with multivariable stepwise logistic
regression analysis an immediate residual gradient of
>30 mmHg as predictor of restenosis. In a third
study, Demkow et al38 described some similar ﬁnd-
ings with a residual gradient of >40 mmHg after the
procedure carrying a sixfold increase in relative risk
for reintervention for restenosis. Although these studies
have demonstrated similar outcomes and associated risk
function, systematic comparison of different series are
of limited value because of heterogeneous population,
non-contemporary timeframes, lack of uniformity in
deﬁning restenosis, and variables criteria to determine
the need of reintervention.
Left ventricular posterior wall thickness
Interestingly, we also found an initial echocardiographic
factor as predictor of reintervention. The increased left
ventricular posterior wall thickness before ﬁrst inter-
vention was independently associated with shorter
freedom from reintervention. In the literature, we did
not ﬁnd a study highlighting these relationships. To
ﬁnd further implication of this parameter, it would be
necessary to conduct a prospective randomised study.
Study limitations
There are several limitations to this study. The primary
limitation is its retrospective design and the extended
enrolment period, a process that may limit the applic-
ability of our ﬁndings. For example, there has been
substantial evolution in balloon technology, which may
have inﬂuenced both technical variables and outcomes.
Similarly, the patients have not been randomised in
one group or the other, and thus the responsibility of
intervention with balloon valvuloplasty or surgical val-
votomy was incumbent on the surgeon or cardiologist
and was not necessarily consistent over the course of the
study period. In addition, this analysis is from a single
institution, and the number of patients is relatively
small and heterogeneous, and thus the results may not
necessarily be generalisable to all patients with con-
genital aortic valve stenosis.
Conclusion
This study conﬁrms that ﬁrst intervention is a safe
and effective procedure to provide a signiﬁcant acute
relief of congenital aortic stenosis. Owing to the
progressive nature of this pathology and the palliative
incidence of ﬁrst intervention, sooner or later a rein-
tervention would be necessary. Factors increasing the
risk of reintervention include increased left ventricular
posterior wall thickness pre-intervention, prior balloon
valvuloplasty, higher residual peak systolic valve
gradient, and more than mild regurgitation post-
intervention. The study highlights that long-term or
even life follow-up is recommended for these
patients. Our ﬁndings should inform and help the
specialist in his decision making for the long-term
follow-up of congenital aortic valve stenosis.
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